Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 31, Number 1—January 2025
Online Report

Research and Development of Medical Countermeasures for Emerging Infectious Diseases, China, 1990–2022

Jiyan Ma, Yang Yang, and Yangmu HuangComments to Author 
Author affiliation: Author affiliation: Peking University School of Public Health, Beijing, China

Main Article

Figure 1

Pipeline of medical countermeasures for emerging infectious diseases by technology platform, China, 1990–2022. A) Distribution of medical countermeasures by technology platform; B) distribution of vaccines and therapeutics by technology platform and development phase. Because of limited information, 2 vaccine candidates in preclinical and phase II stages could not be classified by technology platform.

Figure 1. Pipeline of medical countermeasures for emerging infectious diseases by technology platform, China, 1990–2022. A) Distribution of medical countermeasures by technology platform; B) distribution of vaccines and therapeutics by technology platform and development phase. Because of limited information, 2 vaccine candidates in preclinical and phase II stages could not be classified by technology platform.

Main Article

Page created: November 15, 2024
Page updated: December 22, 2024
Page reviewed: December 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external